🇺🇸 FDA
Pipeline program

Anti-CLL1 CART cells

BG-CT-19-005

Phase 1 small_molecule active

Quick answer

Anti-CLL1 CART cells for Acute Myeloid Leukemia is a Phase 1 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Acute Myeloid Leukemia
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials